English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  53110224    ???header.onlineuser??? :  744
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"gow c h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-25 of 104  (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-08-19T00:21:10Z Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer Yang P.-C.; Chang G.-C.; CHIUN HSU; Gow C.-H.; Yang C.-H.; Shih J.-Y.; Chen K.-C.; Yu C.-J.; Yang T.-Y.; Lin C.-P.; Su W.-P.
臺大學術典藏 2022-06-27T07:07:54Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; CHONG-JEN YU; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:54Z Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Wu S.-G.; Gow C.-H.; CHONG-JEN YU; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:51Z Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; CHONG-JEN YU; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2022-06-27T07:06:37Z Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R Gow C.-H.; Shih J.-Y.; Chang Y.-L.; CHONG-JEN YU
臺大學術典藏 2022-06-27T07:06:35Z Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer Shih J.-Y.; Gow C.-H.; CHONG-JEN YU; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:33Z Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer Yang C.-H.; Shih J.-Y.; Chen K.-C.; CHONG-JEN YU; Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:28Z Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response Gow C.-H.; Chien C.-R.; Chang Y.-L.; Chiu Y.-H.; Kuo S.-H.; Shih J.-Y.; Chang Y.-C.; CHONG-JEN YU; Yang C.-H.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:21Z Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; CHONG-JEN YU; Shin J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:21Z Clinical response of gefitinib on malignant pleural effusions in patients with non-small cell lung cancer Chen C.-H.; Gow C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu Y.-C.; Lee W.-Y.; Yang P.-C.; Kuo S.-H.
臺大學術典藏 2022-03-04T05:33:44Z Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; CHEN-TU WU; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2022-01-08T04:31:30Z Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma Gow C.-H.; MIN-SHU HSIEH; Liu Y.-N.; Lee Y.-H.; Shih J.-Y.
臺大學術典藏 2021-11-03T02:33:00Z Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma Gow C.-H.; Hsieh M.-S.; Liu Y.-N.; Lee Y.-H.; JIN-YUAN SHIH
臺大學術典藏 2021-07-06T02:04:00Z Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer Gow C.-H.; Liu Y.-N.; Li H.-Y.; Hsieh M.-S.; Chang S.-H.; Luo S.-C.; Tsai T.-H.; PEI-LUNG CHEN; Tsai M.-F.; Shih J.-Y.
臺大學術典藏 2021-06-30T08:46:37Z Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Chang Y.-L.;Yu S.-L.;Hsing-Chen Tsai;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; HSING-CHEN TSAI; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2021-05-31T02:57:34Z Primary vascular leiomyosarcoma of the femoral vein leading to metastases of scalp and lungs (multiple letters) [4] Gow C.H.; Liaw Y.S.; Chang Y.L.; Chang Y.C.; RONG-SEN YANG
臺大學術典藏 2021-05-02T03:49:13Z miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-�eB Pathway Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Wang H.-Y.;Jin-Yuan Shih; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; Wang H.-Y.; JIN-YUAN SHIH
臺大學術典藏 2021-04-29T05:09:19Z Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; KUAN-YU CHEN; Su W.-P.; Yang P.-C.
臺大學術典藏 2021-03-19T06:57:58Z Primary vascular leiomyosarcoma of the femoral vein leading to metastases of scalp and lungs (multiple letters) [4] Gow C.H.;Liaw Y.S.;Chang Y.L.;Yeun-Chung Chang;Yang R.S.; Gow C.H.; Liaw Y.S.; Chang Y.L.; YEUN-CHUNG CHANG; Yang R.S.
臺大學術典藏 2021-03-19T06:57:55Z Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response Gow C.-H.; Chien C.-R.; Chang Y.-L.; Chiu Y.-H.; Kuo S.-H.; Shih J.-Y.; YEUN-CHUNG CHANG; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2021-03-19T06:57:51Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; YEUN-CHUNG CHANG; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2021-02-23T08:26:39Z Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response Gow C.-H.;Chien C.-R.;Chang Y.-L.;Chiu Y.-H.;Sung-Hsin Kuo;Shih J.-Y.;Chang Y.-C.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Gow C.-H.; Chien C.-R.; Chang Y.-L.; Chiu Y.-H.; SUNG-HSIN KUO; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2020-12-02T02:35:41Z EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer [2] (multiple letters) Shih J.-Y.;Gow C.-H.;Pan-Chyr Yang; Shih J.-Y.; Gow C.-H.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:35:33Z Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer Shih J.-Y.;Gow C.-H.;Yu C.-J.;Yang C.-H.;Chang Y.-L.;Tsai M.-F.;Hsu Y.-C.;Chen K.-Y.;Su W.-P.;Pan-Chyr Yang; Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:49Z Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer Yang C.-H.; Shih J.-Y.; Chen K.-C.; Yu C.-J.; Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Pan-Chyr Yang; Yang C.-H.; PAN-CHYR YANG et al.

Showing items 1-25 of 104  (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page